Abstract
Ro 23-9424 is a novel ester-linked codrug of fleroxacin (Ro 23-6240; AM-833) and the cefotaxime metabolite desacetylcefotaxime. Its potency was determined against over 1,000 organisms and found to be intermediate between those of the two components. More than 99% of members of the family Enterobacteriaceae were inhibited by greater than or equal micrograms of Ro 23-9424 per ml; its MIC for 50% of strains tested ranged from greater than or equal to 0.06 to 1 micrograms/ml. Staphylococci, streptococci, Branhamella catarrhalis, Corynebacterium jeikeium, Bacillus spp., Haemophilus influenzae, Listeria monocytogenes, and the pathogenic Neisseria spp., including oxacillin-resistant Staphylococcus aureus, beta-lactamase-producing strains, and penicillin-resistant pneumococci, were also inhibited by Ro 23-9424. Pseudomonas aeruginosa, Enterococcus spp., and Bacteroides fragilis group isolates were more refractory to Ro 23-9424 (the MIC for 90% of strains tested was less than or equal to 32 micrograms/ml). Overall, Ro 23-9424 inhibited 97% of the aerobic strains, compared with 90% for ceftazidime and 92% for cefoperazone. Ro 23-9424 was bactericidal, was relatively stable to inoculum effects on MICs at 10(7) CFU/ml, and was determined t...Continue Reading
References
Aug 1, 1976·Antimicrobial Agents and Chemotherapy·D Greenwood, F O'Grady
Jul 1, 1977·The Journal of Antimicrobial Chemotherapy·E Grunberg, R Cleeland
Aug 1, 1976·Antimicrobial Agents and Chemotherapy·C H O'CallaghanS E Staniforth
Jun 1, 1986·Antimicrobial Agents and Chemotherapy·K HiraiT Irikura
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·N X ChinH C Neu
Sep 8, 1987·Biochemistry·S Mobashery, M Johnston
Oct 1, 1984·The Journal of Antimicrobial Chemotherapy·A P BallD Ghosh
Sep 1, 1984·The Journal of Antimicrobial Chemotherapy·R N Jones
Jul 1, 1982·The Journal of Antimicrobial Chemotherapy·S Hartley, R Wise
Sep 1, 1982·Reviews of Infectious Diseases·R N Jones, C Thornsberry
Sep 1, 1982·Reviews of Infectious Diseases·R N JonesC Thornsberry
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·S M HardingJ Ayrton
Oct 1, 1980·The Journal of Antibiotics·B BaltzerS Vangedal
May 1, 1981·The Journal of Antimicrobial Chemotherapy·R Wise
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman
Citations
Oct 1, 1993·Journal of Clinical Pharmacology·S M QadriB A Cunha
Jun 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R N Jones
Jan 1, 1990·Pharmacology & Therapeutics·S Rádl
May 1, 1990·Diagnostic Microbiology and Infectious Disease·R N Jones
Aug 1, 1992·Diagnostic Microbiology and Infectious Disease·K E AldridgeM S Gelfand
Jan 1, 1994·Diagnostic Microbiology and Infectious Disease·R N Jones, M L Sanchez
May 1, 1995·Diagnostic Microbiology and Infectious Disease·D H Wittmann
Apr 17, 1999·Il Farmaco·D AlbaneseM Zenoni
Oct 1, 1990·Antimicrobial Agents and Chemotherapy·J G ChristensonA Specian
Feb 1, 1990·Antimicrobial Agents and Chemotherapy·J W Gu, H C Neu
May 1, 1991·Antimicrobial Agents and Chemotherapy·J PaceN H Georgopapadakou
Jul 5, 2005·Expert Opinion on Investigational Drugs·A Dalhoff
Jul 2, 2005·Expert Opinion on Investigational Drugs·A Bryskier
Feb 11, 2016·Bioorganic & Medicinal Chemistry·Dražen Pavlović, Stjepan Mutak
Nov 6, 2015·Molecular Biology and Evolution·Kathy K WangRoy Kishony
May 10, 2016·Expert Opinion on Drug Delivery·Ibrahim A AljuffaliJia-You Fang
May 23, 2017·Natural Product Reports·P Klahn, M Brönstrup
Jul 1, 2008·Expert Review of Clinical Pharmacology·Marion Skalweit Helfand
Mar 16, 2018·Clinical Microbiology Reviews·Ronald DomalaonFrank Schweizer
Jan 14, 2021·International Journal of Molecular Sciences·Margherita De RosaAnna Marabotti
Feb 20, 2021·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Qais Z Jaber, Micha Fridman
Oct 29, 1993·Journal of Chromatography·A J Szuna, R W Blain
Apr 1, 1992·Antimicrobial Agents and Chemotherapy·K V RolstonG P Bodey